At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 83 enrolled
Drug / intervention
S (+) Ketamine +1 moredrug
Likely dose
S (+) Ketamine 0,35 mg/kgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Effect of Perioperative i.v. Low-dose S(+) Ketamine in Patients Undergoing Hemorrhoidectomy
In Brief
A Phase 4 clinical trial evaluating S (+) Ketamine and Placebo for Hemorrhoids and Pain. Completed, enrolled 83 participants across 1 site.
Detailed Summary
The purpose of this study is to determine whether the use of perioperative intravenous S (+) ketamine reduces the amount and degree of postoperative pain. Furthermore the purpose of this study is to determine whether the use of perioperative intravenous S (+) ketamine effects cognitive function in the early postoperative period.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHemorrhoids, Pain
CountriesNorway
Collaborators--
Timeline
Phase 4CompletedFinished
2006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedJul 2006
Enrollment StartAug 2006
Primary CompletionJun 2008
Study CompletionMay 2009
TodayJul 2026
First PostedJul 19, 2006
Enrollment StartAug 1, 2006
Primary CompletionJun 1, 2008
Study CompletionMay 1, 2009
TodayJul 2, 2026
Enrollment to primary: 1.8 yearsPosted 20.0 years ago
Interventions
S (+) Ketaminedrug
0,35 mg/kg bolus after induction of anaesthesia; 5 ug/kg/min. continuous until the end of surgery
Placebodrug
isotonic saline